Pregled bibliografske jedinice broj: 1056279
Second line treatment for heliobacter pylori infection: Moxifloxacin based triple therapy vs sequential therapy: P1379 H. pylori
Second line treatment for heliobacter pylori infection: Moxifloxacin based triple therapy vs sequential therapy: P1379 H. pylori // Journal of gastroenterology and hepatology, 28 (2013), 545-546 (međunarodna recenzija, ostalo, znanstveni)
CROSBI ID: 1056279 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Second line treatment for heliobacter pylori
infection: Moxifloxacin based triple therapy vs
sequential therapy: P1379 H. pylori
Autori
Bago, Josip ; Halle, Željka ; Bakula, Vinko ; Perić, Rosana ; Marusic, Marinko ; Luetic, Kresimir ; Jurcic, Dragan ; Bilic, Ante ; Dominkovic, Anto
Izvornik
Journal of gastroenterology and hepatology (0815-9319) 28
(2013);
545-546
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, ostalo, znanstveni
Ključne riječi
Helicobacter pylori, moxifloxacin, sequential therapy
Sažetak
The efficacy of moxifloxacin based triple therapy vs sequential therapy as a second line treatment is presented in this work.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinička bolnica "Sveti Duh",
Medicinski fakultet, Osijek
Profili:
Ante Bilić
(autor)
Vinko Bakula
(autor)
Dragan Jurčić
(autor)
Marinko Marušić
(autor)
Krešimir Luetić
(autor)
Josip Bago
(autor)